Several randomized controlled trials have revealed a survival advantage of concurrent chemoradiotherapy (CCRT) in the management of uterine cervical cancer. This paper reviewed the results presented in the literatures and discussed some problems of this strategy.
CITATION STYLE
Toita, T., Tamaki, W., Ogawa, K., Iraha, S., Kakinohana, Y., & Murayama, S. (2005). Chemoradiotherapy for uterine cervical cancer. Japanese Journal of Clinical Radiology.
Mendeley helps you to discover research relevant for your work.